In contrast, supplementation of human plasma-derived AAT to the culture medium did not modulate neutrophil apoptotic cell death, arguing for altered biological activity of AAT in SIRS patients. This evidence concerns the gene SERPINA1 and systemic inflammatory response syndrome.